阿托伐他汀治疗老年人颈动脉粥样硬化斑块的临床观察.pdf阿托伐他汀治疗老年人颈动脉粥样硬化斑块的临床观察.pdf

收藏 分享

资源预览需要最新版本的Flash Player支持。
您尚未安装或版本过低,建议您

NULLNULLDSN2010,325389NULL391JOURNALNULLOFNULLSHANDONGNULLMEDICALNULLCOLLEGEBRM—V54山东医学高等专科学校附属医院,山东临沂276004NULLNULLK1NULL观察阿托伐他汀对老年人颈动脉粥样硬化斑块的治疗效果BZENULL将经超声检查发现存在颈动脉粥样斑块的116例患者随机分为治疗组和对照组,各58例B治疗组给予阿托伐他汀10MGNULLD,顿服B对照组采用饮食控制或服用烟酸A非诺贝特等非他汀类药物B分别于入院时A治疗6A12个月动态监测两组患者的血脂水平,并进行颈动脉超声检查,评估颈动脉斑块积分B比较两组患者血脂和颈动脉斑块积分的变化BTNULL所有116例患者完成了1年的治疗B血脂水平治疗组与用药前相比,治疗6A12个月时TCATGALDL明显降低,HDL明显升高P005;而对照组与治疗前比较则无统计学意义P005B6A12个月时治疗组TCATGALDL明显低于对照组,HDL明显高于对照组P005B颈动脉斑块积分治疗组在6A12个月复诊时左A右侧颈动脉斑块积分与用药前相比有显著性降低P001,对照组则无统计学意义P005B在6A12个月时治疗组左A右侧颈动脉斑块积分均低于对照组P001B‚NULL阿托伐他汀除有良好的降脂作用外还有延缓甚至减轻动脉粥样硬化的作用B1OM阿托伐他汀;颈动脉斑块;老年人NULLNULLDOI103969NULLJISSN1674NULL0947201005030NULLNULLMS|R5435NULLNULLNULLNULLDSM’ACI|1674NULL0947201005NULL0389NULL03NULLT€E1969NULL,3,8›E,1995M8ZMVD,D,CVY5T,XV‚9BNULLL2010NULL04NULL03CLINICALOBSERVATIONONATORVASTATINTREATMENTINTHECAROTIDATHEROSCLEROSISPLAQUEXUMUNULLMINTHEAFFILIATEDHOSPITALOFSHANDONGMEDICALCOLLEGE,LINYI,CHINA,276004ABSTRACTOBJECTIVETOOBSERVETHEEFFECTOFATORVASTATINONCAROTIDATHEROSCLEROSISININGERONTALPATIENTSMETHODS116PATIENTSWITHCAROTIDARTERYPLAQUEWEREDIVIDEDINTOTWOGROUPSRANDOMLY58PATIENTSWERETREATNULLEDWITHATORVASTATIN10MGPERNIGHTFOR12MONTHS58PATIENTSWERETREATEDWITHOUTATORVASTATIN,ANDCONSIDNULLEREDASCONTROLGROUPTHEFASTINGBLOODLIPIDLEVELANDCAROTIDARTERYPLAQUESSCOREWEREMEASUREDATTHEBEGINNULLNINGOFTHESTUDYATHE6THMONTHANDTHE12THMONTHINBOTHGROUPSRESULTSALL116CASESPATIENTSCOMPLETETREATMENTOF12MONTHSTHEBLOODLIPIDLEVELATTHE6THAND12THMONTHSNULLTREATMENT,COMPAREDWITHTHEBEGINNULLNING,THELEVELSOFBLOODTCATGALDLDECREASEDSIGNIFICANTLY,HDLINCREASEDSIGNIFICANTLYP005,WHILETHOSEOFCONTROLGROUPSHOWEDNOSIGNIFICANTDIFFERENCEP005THECAROTIDARTERYPLAQUESSCORETHEREISSTANULLTISTICALLYSIGNIFICANTDIFFERENCEONTHECAROTIDARTERYPLAQUESCOREBETWEENTREATEDANDUNTREATEDGROUPSATBOTH6THMONTHAND12THMONTHINATORVASTATINNULLTREATEDGROUP,THEPLAQUESCORESOFTHEPATIENTSWEREDECREASEDP001WHILETHOSEOFCONTROLGROUPSHOWEDNOSIGNIFICANTDIFFERENCEP005CONCLUSIONTHISSTUDYSUGGESTNULLEDTHATATORVASTATINCOULDPOSSIBLYDELAYEVENLIGHTENTHEPROGRESSIONOFCAROTIDARTERYATHEROSCLEROSISINADDITIONTOTHEIRLIPIDNULLLOWERINGEFFECTSKEYWORDSATORVASTATIN;CAROTIDARTERYPLAQUE;THEAGEDNULLNULLVV1NULL2,R0†‘‰LDLNULLCATGA‰TC,6‘‰HDLNULLC,HEI—VBV,BRYV†T“R‹V†7AA3HHQ3B4BRM€—CASVTB1NULLZE11NULL一般资料NULL2008M32009M1H›2_VŸ€†I†A/0„Ÿ116,385,O31;M5273,6445829;8›V†0B|€SFVF,58,F€HMAŸYA5BY1AŸSP005,V1ŸB12NULL方法NULLFBR,A0ZK/,10MGNULLD,›,IGHF1‹FA†FL0,S,ASI5†BVFœ‚JI›DVDR†0B116€›2_B€,H†,2DV†VL,’VŸ2A†2A2,V€9VVL„VS,›0SYB†_BVSCASBSZE,ZVŸIV’99V9„BJ12HB|5ML,TCATGAHDL„LDLIB„H›6A12HB13NULL统计学处理NULL9NULLXSVU,FW”1T_,1T_,Q1NULL2_B‹SPSS100D9Q›D9SB2NULLT21NULL血脂变化NULLNV1BV1VN,F€0FW1AŸS;F6A12HTCATGAHDLALDL0M1AŸS,TCATGALDLA†,HDLA6;7VF15D9ILB6A12H,FTCATGALDLAHDL1AŸSP005,FTCATGALDLAVF,HDLAVFBV1NULLFVFMNULLXS,CNULLMMOLL10FVF6FVF12FVFTC527087523071452077556076354066575103TG209069205112151070204086118060203116HDL133030131027189036130026226033139034LDL331080316068244066311075205058310090NULLF01P005;VF1P00522NULL颈动脉斑块积分变化NULLNV2BV2VN,0FPAVS1D9IL;F6A12HPAVS0M1AŸ†,VF5D9ILB6A12HFPAVSVFBV2NULLFVFVSMNULLXS,ANULLCM20FVF6FVF12FVFP038028037012024018034014014014031019022011025015016010023022011007022027NULLF01P001;VF1P001390NULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULL山东医学高等专科学校学报NULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULL2010年32卷3NULL‚—KN†ŸD5ŸH,HM1†VA““BCAS†—N„S,8V2_VT4†—3GHS4BV,CAS75HžM15NULL6,7A3QNF76,OVŸM17B}†YCAS1OY,TCATGALDLNULLC6,HDLNULLC†,—T8B2004MREVERSAL952NR0V•Y,LR0,3VCH|,5—4GBSOQB˜2_4BVC—ZDSŸ_ZEBNULLIMT—•ISB8V,IMTVB˜2’,ƒZEVŸ,žƒ2_Ÿ4—HWWM7VFVBBR3NULL3JNULLAHMGNULLCOA4,5†0,VR†TCATGALDL,6HDLBR0D†T3Ÿ9F„FTAL™;5},98‘;M„99˜B‹†T,V7CAS,H|—V,P‚,H„™,HN2BFNBR‚Q‹,F‹BR6VSC/†TBVSMMI‚„3,VSMMBVFVSMBRD†TB6“CF6BRZVCF—R‹,4U‹BR—T05B•ID1NULL,O2,0,‚4ŒBRŸ€ŸY0„•YJM75H,2008,104250NULL2532NULLBLANCKDM,BAKKERNULLARKEMARG,NAWROCKIJWANOVERVIEWOFTHECLINICALSAFETYPROFILEOFATORVASTATINLIPITOR,ANEWHMGNULLCOAREDUCTASEINHIBITORJARCHIVESOFINTERNALMEDNULLICINE,1998,1584577NULL5843NULLSACCORL,BENJAMINEJ,BRODERICKJP,ETALAMERICANHEARTASSOCIATIONPREVENTIONCONFERENCEIVPREVENTIONANDREHANULLBILITATIONOFSTROKERISKFACTORSJSTROKE,1997,2871507NULL15174NULL‹,”8V2_—3HM1ŸZJ5HZ,2003,244306NULL3085NULLBUCCIARELLIP,SRAMEKA,REIBERJH,ETALARTERIALINTINULLMANULLMEDIATHICKNESSANDITSRELATIONSHIPWITHCARDIOVASCULARDISEASEANDATHEROSCLEROSISAPOSSIBLECONTRIBUTIONOFMEDIUMSIZEDARTERNULLIESJTHROMBHAEMOST,2002,886961NULL9666NULLV,,Fž,—3N1J5BD,2006,155441NULL4457NULLJANDERSS,SITZER,WENDTA,ETALEXPRESSIONOFTISSUEFACNULLTORINHIGHNULLGRADECAROTIDARTERYSTENOSISASSOCIATIONWITHPLAQUEDESTABILIZATIONJSTROKE,2001,324850NULL8548NULLCASSCELLSW,NAGHAVIM,WILLERSONJTVULNERABLEATHEROSCLEROTICPLAQUEAMULTIFOCALDISEASEJCIRCULATION,2003,1071620729NULLNISSENSE,TUZCUEM,SCHOENHAGENP,ETALEFFECTOFINTENSIVECOMPAREDWITHMODERATELIPIDLOWERINGTHERAPYONPRONULLGRESSIONOFCORONARYATHEROSCLEROSISJJAMA,2004,29171071NULL1080编辑NULL胡怀富391NULLNULL5期NULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULL徐穆民阿托伐他汀治疗老年人颈动脉粥样硬化斑块的临床观察NULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULLNULL
编号:201312191347595999    类型:共享资源    大小:161.00KB    格式:PDF    上传时间:2013-12-19
  
5
关 键 词:
管理 组织 经营
  人人文库网所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
关于本文
本文标题:阿托伐他汀治疗老年人颈动脉粥样硬化斑块的临床观察.pdf
链接地址:http://www.renrendoc.com/p-245999.html

当前资源信息

4.0
 
(2人评价)
浏览:14次
abingge上传于2013-12-19

官方联系方式

客服手机:17625900360   
2:不支持迅雷下载,请使用浏览器下载   
3:不支持QQ浏览器下载,请用其他浏览器   
4:下载后的文档和图纸-无水印   
5:文档经过压缩,下载后原文更清晰   

相关搜索

精品推荐

相关阅读

人人文库
关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服客服 - 联系我们

网站客服QQ:2846424093    人人文库上传用户QQ群:460291265   

[email protected] 2016-2018  renrendoc.com 网站版权所有   南天在线技术支持

经营许可证编号:苏ICP备12009002号-5